精准肿瘤学公司Guardant Health（GH）在夜盘交易中股价大幅下跌7.59%，引发市场广泛关注。这一显著跌幅主要源于公司最新宣布的大规模融资计划。
据悉，Guardant Health计划发行2.5亿美元的新股，同时非公开发行3亿美元、2033年到期的可转换债券。公司表示，此次融资所得将用于一般企业用途，包括回购部分2027年到期的0%可转换债券，以及潜在的互补产品和技术收购。这一举措引发了投资者对股权稀释的担忧，进而导致股价下跌。
尽管短期内股价承压，但Guardant Health的长期表现仍然强劲。该股在过去一周上涨了41%，今年以来更是上涨了两倍多。分析师对公司前景保持乐观，在25位分析师中，23位给予"强力买入"或"买入"评级。值得注意的是，根据LSEG数据，分析师对该股的目标价中值为100美元，高于一个月前的68美元，显示出市场对公司未来发展仍持积极态度。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.